NEW DERIVATIVES OF AMINOCYCLOHEXANE Russian patent published in 2004 - IPC

Abstract RU 2225393 C1

FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to new compounds of the formula (I): wherein U means oxygen atom or unshared one-pair electrons; V means oxygen, sulfur atom, -CH2-, -CH=CH- or ; W means CO, COO, CONR1, CSO, CSNR1, SO2 or SO2NR1; m and n each means independently of one another a number from 0 to 7, and sum m + n is from 0 to 7 under condition that m doesn't mean 0 if V means oxygen or sulfur atom; A1 means hydrogen atom, lower alkyl, hydroxy(lower)alkyl or (lower)alkenyl; A2 means (lower)alkyl, cycloalkyl, cycloalkyl(lower)alkyl or (lower)alkenyl optionally substituted with the group R2; A3 and A4 each means hydrogen atom or (lower)alkyl; A5 means hydrogen atom, (lower)alkyl, (lower)alkenyl or aryl(lower)alkyl; A6 means (lower)alkyl, cycloalkyl, aryl, aryl(lower)alkyl, heteroaryl, heteroaryl(lower)alkyl, (lower)alkoxycarbonyl(lower)alkyl; R2 means hydroxy-group, hydroxy(lower)alkyl, (lower)alkoxy-group, (lower)alkoxycarbonyl, N(R4,R5) or thio(lower)alkoxy- -group; R1, R3, R4, R5 each means independently of one another hydrogen atom or (lower)alkyl; and to their pharmaceutically acceptable salts and/or pharmaceutically acceptable esters. These compounds can be used in treatment and/or prophylaxis of diseases associated with 2,3-oxidosqualenlanosterol cyclase, such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycosis and parasitic infections. EFFECT: valuable medicinal and biochemical properties of compounds. 35 cl, 1 tbl, 55 ex

Similar patents RU2225393C1

Title Year Author Number
SUBSTITUTED DERIVATIVES OF CYCLOHEXANE 2002
  • Akkermann Zhan
  • Ehbi Iogannes
  • Demlov Genrietta
  • Khirt Zhorzh
  • Merki Khans-Peter
  • Moran Oliv'E
RU2288221C2
DERIVATIVES OF HETEROARYL-SUBSTITUTED AMINOCYCLOHEXANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2002
  • Akkermann Zhan
  • Ehbi Iogannes
  • Demlov Genrietta
  • Merki Khans-Peter
  • Moran Oliv'E
RU2286987C2
NON-PEPTIDE ANTAGONISTS GnRH 2003
  • Rou Majkl Brajan
  • Batt Andrzhej Roman
  • Ivanz Dejvid Majkl
  • Pitt Gehri Robert Uil'Jam
  • Ruker Dejvid Filip
RU2329251C2
CATALYST SYSTEM 2003
  • Istkhehm Grehkham
  • Batler Ian
  • Fort'Jun Kevin
RU2326123C2
HETEROCYCLIC CONDENSED COMPOUNDS USEFUL AS ANTIDIURETIC AGENTS 2005
  • Pitt Gari Robert Uil'Jam
RU2359969C2
CONDENSED AZEPINES, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF, METHOD FOR TREATMENT BY USING INDICATED COMPOSITION 2001
  • Ashuehrt Dorin Mehri
  • Pitt Gari Robert Uil'Jam
  • Khadson Piter
  • Jej Kristofer Martin
  • Franklin Richard Dzheremi
RU2259367C2
AQUEOUS TWO-COMPONENT POLYURETHANE COATING MATERIAL, METHOD OF PREPARATION THEREOF, AND ITS UTILIZATION IN MANUFACTURING LAYERED LACQUER COATING 1994
  • Ehgbert Nienkhaus
  • Bernd Majer
  • Uve Majzenburg
RU2136713C1
SOMATOSTATIN RECEPTOR ANTAGONISTS 1997
  • Morgan Behrri
  • Merfi Vill'Jam
  • Koj Dehvid Kh.
RU2179172C2
HERBICIDAL COMPOSITION AND METHOD FOR WEED CONTROLLING 1999
  • Khaker Ehrvin
  • Biringer Khermann
  • Auler Tomas
  • Vil'Ms Lotar
  • Minn Klemens
  • Khollander Jens
  • Zindel' Jjurgen
  • Ginke Vol'Fgang
RU2261598C9
MALONAMIDE DERIVATIVES AS γ-SECRETASE INHIBITORS 2007
  • Flor Aleksander
  • Jakob-Retne Roland
  • Vostl' Vol'Fgang
RU2440342C2

RU 2 225 393 C1

Authors

Akkermann Zhan

Ehbi Iogannes

Blum Deniza

Chucholovski Aleksander

Demlov Genrietta

Mehrki Khans-Peter

Moran Oliv'E

Trussardi Rene

Fon-Der-Mark Ehlizabet

Vall'Baum Zabine

Veller Tomas

Dates

2004-03-10Published

2001-08-08Filed